Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications cost effectiveness nusinersen treatment patients infantile onset later onset spinal
… A Cost-Effectiveness Analysis Using Real-World Data William Herring, … PhD Director, Health Economics RTI Health Solutions A Cost-Effectiveness Analysis Using Real-World Data from the … MSBase Registry: Comparing Natalizumab to Fingolimod in Patients with Inadequate Response to Disease-Modifying …
… Tailoring Cost-Effectiveness Modeling Methodologies for Multiple Sclerosis Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in patients with inadequate response to disease-modifying …
… to calculate quality-adjusted life years [QALYs] in cost-effectiveness analyses) or other evaluations for health care … such as NICE, SMC, CDR, and PBAC), value messaging , and publications A Team Approach Let our multidisciplinary team …
… studies, we can help you can gain insights on: Burden (cost) of illness Cost of treatment Health care resource utilization Treatment patterns … adherence, persistence, and compliance Comparative effectiveness and costs of alternative treatments Disease …
… Willingness-to-Pay Given your product’s treatment features, do you know how much your patient’s value … dosing regimen changes from 3 times a day to 1? Length of treatment decreases to 5 days instead of 10? The delivery …
… risks and benefits, patient-centricity, and comparative effectiveness continue to be the driving themes within the … , and drug safety leaders, we can help you with: Burden/cost of Illness Disease prevalence and incidence Treatment … and retention Statistical analysis plans Reports and publications Data Collection and Management Depending upon …
… decreases in the efficacy of platelets, which meant that patients needed significantly more PC units for transfusion in order to get the desired treatment effect. Researchers concluded that “Although it …
… What Do Patients with Parkinson’s Disease Value Most In Off-Episode … Food and Drug Administration has approved three on-demand treatment therapies to relieve these episodes. It was not … to relieve symptoms) How long symptom relief would last Cost Overall, respondents placed the most importance on …
… evolving body of evidence in a particular disease or treatment area. High-quality literature reviews can help you: … and patterns in clinical practice Identify clinical and cost effectiveness of comparator treatments Formulate best …
… for making your healthcare interventions available to patients is being able to meet regulatory requirements for estimating the product's safety and/or effectiveness using real-world data (RWD). This most often …